Answers are grounded in this paper and cite their sources.
Multicenter cohort study demonstrates BIA-derived ratios predict survival outcomes in gastric cancer, suggesting new prognostic markers.
Bioelectrical impedance analysis (BIA)-derived water composition ratios are non-invasive and cost-effective indices that reflect body fluid distribution. This study aimed to investigate the associations between these BIA-derived ratios and overall survival (OS) in patients with gastric cancer. A retrospective multicenter study included 385 gastric cancer patients. Optimal cutoffs were determined via Receiver Operating Characteristic (ROC) curves. Kaplan-Meier survival analysis, Cox regression analysis, and restricted cubic spline (RCS) evaluated associations with OS. The optimal cutoff values were 0.389 for extracellular water (ECW)/total body water (TBW), 0.611 for intracellular water (ICW]/TBW, and 0.638 for ECW/ICW. Kaplan-Meier survival analysis revealed that elevated ECW/TBW (72.6% vs. 58.7%; p<0.001) and ECW/ICW (59.1% vs. 72.4%; p<0.001) were associated with poorer OS, while a higher ICW/TBW (73.4% vs. 57.3%; p<0.001) indicated better prognosis. In RCS models, ECW/TBW (HR=1.552, 1.202-2.005, p=0.001) and ECW/ICW (HR=1.735, 1.320-2.280, p<0.001) independently predicted worse OS, whereas ICW/TBW inversely correlated with mortality (HR=0.620, 0.486-0.790, p<0.001). Multivariable Cox regression analysis further confirmed that higher ECW/TBW (HR=1.552, 95% CI 1.272-2.688, p<0.001) and ECW/ICW (HR=1.735, 1.320-2.280, p<0.001) ratios independently predicted worse OS. Conversely, a higher ICW/TBW ratio was inversely correlated with mortality (HR=0.567, 95% CI 0.390-0.824, p=0.003). The ECW/ICW ratio demonstrated the highest C-index (0.596), outperforming other ratios in predicting survival. These associations were consistent across subgroups, including advanced-stage patients. BIA-derived water composition ratios, particularly ECW/ICW, are robust and independent predictors of survival in gastric cancer patients, reflecting underlying metabolic and inflammatory disturbances. These non-invasive and cost-effective markers could enhance prognostic accuracy and guide personalized treatment strategies.
No takes yet. Share an insight, caveat, or question.
Wei et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: